Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

A.C.E.| Seminar 1:Building a strong patent portfolio to gain market competitive advantages

Page View:


Starting from 2023, Medicilon will host a series of webinars with a wide range of critical topics in biotech industry, including IP strategies, licensing, M&A, investment, due diligence, finance, company management, the business environment between United States and China, as well as how Medicilon can support with its 20 years of establishment and new research and technology platforms.

During the webinars, Medicilon will invite a group of senior industrial experts and executives in related fields to systematically introduce the ideas and key elements, share their experience, and conduct the in-depth discussions. We sincerely invite you to join us!



About Medicilon

Medicilon is a professional pharmaceutical preclinical integrated R&D service contract research organization (CRO), providing a full range of one-stop new drug R&D services, in compliance with Chinese and international filing standards, to pharmaceutical companies and research institutions around the world. Our services cover the entire process of preclinical new drug research, including drug discovery, pharmacology research and preclinical research.

We focus on the needs of innovation and development of global pharmaceutical industry, based on the key aspects of R&D of innovative drug, and build a comprehensive technology platform covering drug discovery, pharmacological research and preclinical research key technologies with our rich experience in serving the Chinese and international biopharmaceutical industry.

For enquiries, please email .

Click to register


#ACE #licensing #investment #drug discovery #medicilon

Relevant newsRelevant news